Inventor · disambiguated record
Michael H. Kagey
Also filed as: KAGEY MICHAEL · KAGEY MICHAEL H
4 granted patents·5 pending applications·8 citations·filing 2009–2022
67Inventor score
Top patents by PatentIndex Score
9 records- 0179US12319730B2Use of beta-catenin as a biomarker for treating cancers using anti-Dkk-1 antibodyLEAP THERAPEUTICS INC·Filed 2022·Granted Jun 3, 2025·1 cites·16 claims
- 0276US10124009B2Bromodomain inhibitorsTENSHA THERAPEUTICS INC·Filed 2015·Granted Nov 13, 2018·4 cites·10 claims
- 0375US11267876B2Use of beta-catenin as a biomarker for treating cancers using anti-dkk-1 antibodyLEAP THERAPEUTICS INC·Filed 2017·Granted Mar 8, 2022·2 cites·13 claims
- 0466US10925881B2Treatment of conditions associated with hyperinsulinaemiaTENSHA THERAPEUTICS INC·Filed 2015·Granted Feb 23, 2021·1 cites·16 claims
- 0550US2012034192A1Compositions and methods for enhancing cell reprogrammingYOUNG RICHARD A·Filed 2009·Application pending·0 cites
- 0645US2024141023A1Methods of treating cancer using dkk-1 inhibitorsLEAP THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0741US2022381786A1Use of dkk-1 inhibitors for treating cancerLEAP THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0837US2013109737A1Mediator and cohesin connect gene expression and chromatin architectureYOUNG RICHARD A·Filed 2011·Application pending·0 cites
- 0934US2018193350A1Treatment of nut midline carcinomaTENSHA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael H. Kagey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →